Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 17/20 | 0.65 |
| ▸ | PPARA | Q07869 | 16/20 | 0.65 |
| ▸ | PPARD | Q03181 | 9/20 | 0.65 |
| ▸ | PHGDH | O43175 | 1/20 | 0.42 |
| ▸ | GALR3 | O60755 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2807596 | 0.91 | PPARG (0.76) | PPARGPPARAPPARDPHGDH | |
| SCHEMBL4694833 | 0.88 | PPARA (0.82) | PPARGPPARAPPARD | |
| SCHEMBL4691381 | 0.87 | PPARG (0.71) | PPARGPPARAPPARDPHGDH | |
| SCHEMBL4787025 | 0.84 | PPARA (0.80) | PPARGPPARAPPARDPHGDHRAB9A | |
| SCHEMBL4691715 | 0.83 | PPARG (0.60) | PPARGPPARAPPARDPHGDHGALR3 | |
| SCHEMBL4695991 | 0.82 | PPARG (0.84) | PPARGPPARAPPARD | |
| SCHEMBL4750579 | 0.81 | PPARG (0.66) | PPARGPPARAPPARDPHGDH | |
| SCHEMBL2787266 | 0.81 | PPARG (0.79) | PPARGPPARAPPARDPHGDH | |
| SCHEMBL4695138 | 0.80 | PPARG (0.72) | PPARGPPARAPPARDPHGDH | |
| SCHEMBL4689581 | 0.80 | PPARG (0.69) | PPARGPPARAPPARDPHGDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1685113-B1 | SUBSTITUTED PYRAZOLES AS PPAR AGONISTS | SMITHKLINE BEECHAM CORP (US) | 2008-07-30 | — | — | EP | disclosed |
| US-20080021030-A1 | Substituted Pyrazoles As Ppar Agonists | SMITHKLINE BEECHAM CORPORATION | 2008-01-24 | — | — | US | disclosed |
| US-20080021030-A1 | Substituted Pyrazoles As Ppar Agonists | SMITHKLINE BEECHAM CORPORATION | 2008-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021030-A1 | Substituted Pyrazoles As Ppar Agonists | PPARD, PPARA, PPARG | PPARG 3/4885PPARA 2/4885PPARD 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.